<table-wrap xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" id="tbl1" position="float"><object-id pub-id-type="doi">10.7554/eLife.16090.006</object-id><label>Table 1.</label><caption><p>Summary of data collated in the three meta-analyses. The number of data points is subdivided according to the insecticides or LLIN tested and the predominant mosquito species in each population tested. Studies which did not determine species in the <italic>Anopheles gambiae</italic> complex are shown separately. All Published Data can be downloaded from Dryad Digital Repository whilst a list of the studies included their geographical range are given in the Material and methods.</p><p><bold>DOI:</bold> <ext-link ext-link-type="doi" xlink:href="10.7554/eLife.16090.006">http://dx.doi.org/10.7554/eLife.16090.006</ext-link></p></caption><table frame="hsides" rules="groups"><thead><tr><th colspan="2" rowspan="2">Meta-analysis description</th><th rowspan="2">Details</th><th rowspan="2">No. Studies</th><th colspan="5">Number data points</th></tr><tr><th><italic>Anopheles gambiae</italic> s.s.</th><th><italic>Anopheles arabiensis</italic></th><th><italic>Anopheles gambiae</italic> s.l.</th><th><italic>Anopheles funestus</italic></th><th><bold>Total</bold></th></tr></thead><tbody><tr><td rowspan="4" valign="top"><italic><bold>M1</bold></italic></td><td rowspan="4" valign="top"><italic>Bioassay and experimental hut trial mortality</italic></td><td valign="top">Deltamethrin</td><td>5</td><td>2</td><td>1</td><td>10</td><td>0</td><td>13</td></tr><tr><td valign="top">Permethrin</td><td>8</td><td>2</td><td>1</td><td>3</td><td>0</td><td>6</td></tr><tr><td valign="top">Other</td><td>1</td><td>0</td><td>0</td><td>1</td><td>1</td><td>2</td></tr><tr><td valign="top"><bold>Total</bold></td><td>13</td><td>4</td><td>2</td><td>14</td><td>1</td><td><bold>21</bold></td></tr><tr><td rowspan="4" valign="top"><italic><bold>M2</bold></italic></td><td rowspan="4" valign="top"><italic>Impact of PBO in pyrethroid bioassays</italic></td><td valign="top">Deltamethrin</td><td>16</td><td>15</td><td>5</td><td>29</td><td>8</td><td>57</td></tr><tr><td valign="top">Permethrin</td><td>20</td><td>22</td><td>7</td><td>30</td><td>9</td><td>68</td></tr><tr><td valign="top">Other</td><td>4</td><td>2</td><td>0</td><td>4</td><td>6</td><td>12</td></tr><tr><td valign="top"><bold>Total</bold></td><td>24</td><td>39</td><td>12</td><td>63</td><td>23</td><td><bold>137</bold></td></tr><tr><td rowspan="3" valign="top"><italic><bold>M3</bold></italic></td><td rowspan="3" valign="top"><italic>Experimental hut trials of standard and PBO LLINS</italic></td><td valign="top">Olyset</td><td>6</td><td>6</td><td>0</td><td>10</td><td>0</td><td>16</td></tr><tr><td valign="top">PermaNet</td><td>6</td><td>18</td><td>4</td><td>6</td><td>0</td><td>28</td></tr><tr><td valign="top"><bold>Total</bold></td><td>12</td><td>24</td><td>4</td><td>16</td><td>0</td><td><bold>44</bold></td></tr></tbody></table></table-wrap>